Advertising & Promotion for Medical Products Conference
October 17–18, 2024 In-Person & Virtual Event
Overview
The Advertising and Promotion for Medical Products (A&P) Conference congregates representatives from federal agencies, industry, patient-advocacy groups, and academics to explore government initiatives and priorities concerning medical product advertising and promotion, critical developments in the field, trends in enforcement and regulation, and new technologies. Diverse perspectives, engagement opportunities, and timely subject matter make this a truly unique program with great learning potential.
Fireside Chat
Elizabeth Jungman
Chief of Staff, Office of the Commissioner, FDA
Annie Ugurlayan
Assistant Director, National Advertising Division, BBB National Programs
Serena Viswanathan
Associate Director, Division of Advertising Practices, FTC
Register
Sponsors
Sponsorship opportunities are available. Please let us know if you would like more information.
Gold
Silver
Planning Committee
Co-Chairs
Dale Cooke
President, PhillyCooke Consulting
Jae Kim
Partner, DLA Piper LLP (US)
Members
Katie Bond, Keller and Heckman LLP
Hannah R. Bornstein, Nixon Peabody LLP
Dominick P. DiSabatino, Sheppard Mullin Richter & Hampton LLP
Mark Gardner, Gardner Law, PLLC
Abraham Gitterman, Arnold & Porter LLP
Alan G. Minsk, Arnall Golden Gregory LLP
Anisa Mohanty, DLA Piper
Devaki Patel, Alston & Bird LLP
Nancy E. Taylor, Greenberg Traurig, LLP
Sara Wexler Koblitz, Hyman, Phelps & McNamara, PC
Heta Zaveri, Opus Regulatory, Inc.
Call for Proposals
FDLI and the A&P Conference Planning Committee thanks those who participated in the Call for Proposals. If you submitted a proposal, you will be notified of the status of your proposal by late July.
